Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

0.5017
-0.0283-5.34%
Volume:387.93K
Turnover:194.34K
Market Cap:2.78M
PE:-0.01
High:0.5275
Open:0.5140
Low:0.4900
Close:0.5300
Loading ...
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 14, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 09, 2024

Correspondence

Form CORRESP - Correspondence
Apr 09, 2024

Correspondence

Form CORRESP - Correspondence
Mar 30, 2024

Correspondence

Form CORRESP - Correspondence
Mar 29, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 20, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

Correspondence

Form CORRESP - Correspondence
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]